LATISSE 0.03 %
BIMATOPROST : 0.03 % · DIN 02350939 · ABBVIE CORPORATION
Health Canada status: MARKETED
What is LATISSE?
LATISSE 0.03 % contains BIMATOPROST : 0.03 %. It is listed in the Health Canada Drug Product Database under DIN 02350939, held by ABBVIE CORPORATION, supplied as SOLUTION for TOPICAL administration. Health Canada currently lists it as marketed, status dated 21-Jun-2024. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is LATISSE used for?
LATISSE (bimatoprost) is indicated for the treatment of hypotrichosis of the eyelashes by increasing their growth including length, thickness and darkness. Patients without visible eyelashes were not studied.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02350939 |
|---|---|
| Brand name | LATISSE |
| Generic / active ingredient | BIMATOPROST : 0.03 % |
| Manufacturer | ABBVIE CORPORATION |
| Strength | 0.03 % |
| Dosage form | SOLUTION |
| Route of administration | TOPICAL |
| Schedule | Prescription |
| ATC code | S01EE03 BIMATOPROST |
| AHFS class | 52:40.28 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 21-Jun-2024 |
| Original market date | 2010-11-01 00:00:00 |
How is it stored and handled?
null
How is it supplied?
1.5 mL of sterile solution in a 5 mL bottle, accompanied by 40 sterile disposable applicators packaged in a separate blister. These two components, solution and applicators, are combined in a clutch type carton; 3 mL of sterile solution in a 5 mL bottle, accompanied by 60 sterile disposable applicators packaged in a separate blister format. These 2 components, solution and applicators, are combined in a clutch type carton; 3 mL of sterile solution in a 5 mL bottle, accompanied by 80 sterile disposable applicators packaged in a separate blister format. These 2 components, solution and applicators, are combined in a clutch type carton; 5 mL of sterile solution in a 5 mL bottle, accompanied by 140 sterile disposable applicators packaged in a separate blister format. These 2 components, solution and applicators, are combined in a clutch type carton.
What can be used instead?
Other Canadian products sharing ATC code S01EE03 BIMATOPROST. 4 of 8 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| LUMIGAN RC | 0.01 % | SOLUTION | ABBVIE CORPORATION | MARKETED | DIN 02324997 |
| VISTITAN | 0.03 % | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED | DIN 02429063 |
| ZIMED PF | 0.03 % | SOLUTION | AEQUUS PHARMACEUTICALS INC. | MARKETED | DIN 02533464 |
| APO-BIMATOPROST | 0.03 % | SOLUTION | APOTEX INC | APPROVED | DIN 02356279 |
| APO-BIMATOPROST | 0.03 % | SOLUTION | APOTEX INC | APPROVED | DIN 02402505 |
| LUMIGAN | 0.03 % | SOLUTION | ALLERGAN INC | CANCELLED POST MARKET | DIN 02245860 |
| LUMIGAN PF | 0.03 % | SOLUTION | ALLERGAN INC | CANCELLED PRE MARKET | DIN 02400162 |
Who else supplies BIMATOPROST worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. BIMATOPROST appears in 119 registered pack listings across 13 markets, published on 11 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.